Alembic Pharma Q1 Results: Net profit rises 12% YoY to Rs 135 croreEarnings before interest, tax, depreciation and amortisation (EBITDA) rose 14% YoY to Rs 239 crore, while the EBITDA margins contracted 540...
08 Aug, 2024, 08.25 PM IST
Alembic Pharma posts Rs 180 crore net profit in Q3FY24Drug maker Alembic Pharma on Monday reported Rs 180 crore net profit in Q3FY24, which is a 48% year-on-year (YoY) increase compared to the ...
05 Feb, 2024, 05.48 PM IST
Alembic Pharma Q2 Results: Firm posts Rs 137-crore net profitRevenues grew 8% to Rs.1595 crore in Q2FY24 compared to Rs 1475 crore last year. The earnings before interest, tax, depreciation and amorti...
07 Nov, 2023, 07.06 PM IST
Neutral on Alembic Pharmaceuticals, target price Rs 750: Motilal Oswal Financial ServicesAlembic Pharma delivered a better than expected operational performance, led by better-than-industry growth in the Domestic Formulations (D...
04 May, 2022, 11.07 AM IST
Alembic Pharma net profit drops 40% to Rs 176 crore in Q3FY22"India business is going to grow, and continue to grow faster than our represented market, the initiatives we have taken in last few years ...
10 Feb, 2022, 09.15 PM IST
Market Movers: Why Dr Reddy’s fell & took other drug stocks down with itThe biggest trigger for the nose bleeding fall in Dr Reddy's Labs stock was hidden away in the notes to account of the company’s P&L statem...
27 Jul, 2021, 04.26 PM IST
Neutral on Alembic Pharma, target price Rs 1070: Motilal OswalMotilal Oswal has a neutral call on Alembic Pharmaceuticals with a target price of Rs 1070. The current market price of Alembic Pharmaceuti...
05 May, 2021, 01.31 PM IST
Alembic Pharma Q3 results: Net profit rises 25% to Rs 293 croreThe company had posted a net profit of Rs 234.19 crore for the corresponding period of the previous financial year, Alembic Pharmaceuticals...
19 Jan, 2021, 04.14 PM IST
Pharma firms discover glamour in dowdy APIsPharma companies have posted smart growth in API sales for the quarter due to increased demand of certain APIs used in the Covid-19 treatme...
03 Aug, 2020, 06.00 PM IST
Buy Alembic Pharma, target price Rs 1,100: Yes SecuritiesStrong prognosis beyond FY22 gives tremendous support to earnings.
20 May, 2020, 10.58 AM IST
Alembic Pharma Q2 PAT up 25% at Rs 250 croreThe company had posted a consolidated PAT of Rs 200.09 crore in the same quarter last fiscal.
25 Oct, 2019, 12.00 PM IST
With several firms getting USFDA clearances, Street to breathe easy about pharma stocksLast week, Lupin, Cadila Healthcare and Alembic Pharma received clearances from the US regulator for their key facilities.
12 Jul, 2016, 03.55 AM IST
High revenue, profit growth make Alembic analysts' favouriteAlthough both the domestic and the international businesses are doing well, the company is likely to sustain its high growth largely on acc...
15 Feb, 2016, 09.53 AM IST
Alembic Pharmaceuticals Q3 net up 7 per cent at Rs 70.66 croreIt had posted net profit of Rs 65.93 crore in the same quarter of the 2013-14 fiscal, Alembic Pharma said in a filing to the BSE.
04 Feb, 2015, 04.24 PM IST
Alembic Pharma: Further re-rating likely due to high growth rate, strong balance sheetAfter remaining on the sidelines for a decade, Alembic Pharma’s stock has been in the limelight in the recent past.
21 Apr, 2014, 08.08 AM IST
Alembic Pharmaceuticals outshines pharma peers as new drugs spur growth100-year-old Vadodara-based firm, Alembic Pharmaceuticals is the second-best pharma stock in the BSE 500 in the past one year.
07 Nov, 2013, 09.39 AM IST
Alembic Pharma holds long-term promiseOperating margin has improved from 14% a year ago to nearly 17% in the June quarter.
04 Sep, 2013, 08.42 AM IST